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Th ree decades into the HIV epidemic, we have made 
remarkable progress. We have sensitive and speciﬁ c tests 
to detect infection; there are eﬀ ective antiretroviral 
(ARV) drugs to prevent the virus from continuing its 
relentless onslaught on the body’s immune system; we 
can reliably measure treatment success using techniques 
that can determine the level of immunosuppression or 
quantify viral load in plasma; available resistance 
genotyping allows us to detect the emergence of strains 
insensitive to prescribed drugs; and there are guidelines 
to help clinicians switch patients to more eﬀ ective anti-
retroviral combinations.
We also have a relatively sound understanding of how 
to prevent HIV transmission and acquisition; eﬀ ective 
suppression of viral load in patients is believed to 
minimize the risk of HIV transmission, and there is a 
strong conviction that treatment can have a signiﬁ cant 
impact on curbing the epidemic [1]. We also know that 
eﬀ ective and timely treatment of women during preg-
nancy and labour signiﬁ cantly reduces perinatal trans-
mission of HIV. ARV prophylaxis in infants further 
minimizes the risk of HIV acquisition, in particular if 
combined with safe breastfeeding practices [2]. More 
recent data from randomized clinical trials have shown 
that circumcision reduces female-to-male HIV trans-
mission by nearly 60% and that ARV prophylaxis, for 
example, oral pre-exposure prophylaxis with such drugs 
as tenofovir and emtricitabine or the same combination 
in a gel format for topical use, can substantially reduce 
HIV acquisition if used consistently [3-5].
Despite these impressive advancements, in many high-
prevalence settings, the majority of people do not know 
their HIV status, and according to global estimates, a 
mere 36% of those eligible for treatment are currently 
enrolled in treatment programmes [6-8]. In sub-Saharan 
Africa, where the greatest majority of HIV-infected 
children live, only 26% are receiving ARV therapy (ART). 
Moreover, while the treatment needs continue to grow, 
for every person with HIV placed on treatment, two 
more get newly infected. New infections also occur due 
to poor coverage of prevention of mother to child 
transmission programmes, which reach only half of all 
HIV-positive, pregnant women [6]. In sub-Saharan Africa 
particularly, tuberculosis (TB) case notiﬁ cation rates have 
spiralled out of control as a result of co-infection with 
HIV, and, despite eﬀ ective treatment and prevention, TB 
continues to be the most important cause of death in 
people living with HIV, both in the pre-ART era and now, 
in the era of ART [9].
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Th ere are numerous impediments to achieving full 
implementation of all proven strategies, and multifaceted 
programmatic challenges create roadblocks to providing 
universal access to HIV prevention, treatment and care; 
social injustice, economic inequalities and operational 
obstacles continue to interrupt the access to, and the 
continuum of care.
Stigma and discrimination remain major hurdles to 
HIV testing, and hand in hand with persistent use of 
outdated and centralized systems, which lag behind 
modern and more eﬃ  cient technologies, result in delayed 
provision of test results and low retention in care.
Most of sub-Saharan Africa’s health systems were 
organized and geared historically towards the manage-
ment of acute illnesses, and are not orientated to the 
long-term management of chronic diseases, in particular 
to the scale of chronic disease caused by HIV. As a result, 
these health systems may quickly become overwhelmed 
and lack the capacity to carry and support the great 
burden of a growing – and chronic – patient pool. 
Health care providers, often overstretched, continue to 
juggle increasing numbers of patients in urgent need of 
care with limited resources. Th e demands and expec-
tations are not only growing on healthcare providers, but 
on all other cadres of the broader health system. For 
example, reliable drug forecasting and appropriate inven-
tory management to secure an uninterrupted supply of 
medicines and other necessities are indispensable 
elements of a successful ART programme.
Meeting all the needs and overcoming all the obstacles 
costs money. Governments, including those with the 
political will to make a change, struggle with setting 
priorities: balancing demand for ﬁ nancial investment in 
health systems, securing ART programmes through 
bilateral and multilateral relations to meet the urgent 
needs while, at the same time, seeking long-term sustain-
able solutions. Controversies as to whether funding for 
HIV interventions has sidelined investment in other 
health sectors in the context of a dire ﬁ nancial climate 
has perhaps contributed to HIV donor fatigue, which 
may overlook the positive spin-oﬀ  eﬀ ect of HIV funding 
on the broader health infrastructure and health 
outcomes.
Challenges are many and multifaceted, and it is 
increasingly evident that innovative approaches need to 
be conceived to more eﬀ ectively use the scarce and 
shrink ing resources. Th ere is also a need to eﬀ ectively 
address the growing demand within a framework that 
protects human rights and provides access to services 
through a public health approach.
Testimony to this priority shift is the change in termi-
nology found across the literature. Within the HIV litera-
ture, key words have mushroomed, such as economic 
eﬃ  ciency, trade oﬀ s, decentralization, task shifting, task 
sharing, empowerment, community involvement, home-
based care, point-of-care tests for diagnosis and monitor-
ing purposes, treatment simpliﬁ cations, patient self-
management, health system strengthening, and mobile 
technology. Th ere has been a surge of innovative 
approaches and technologies to address the obstacles 
that we have mentioned and to optimize the operation of 
HIV care delivery.
Th e emerging operational research and implementation 
sciences within the HIV ﬁ eld dedicates its eﬀ orts to 
investigating and identifying the best models to deliver 
and implement services in various settings, taking into 
consideration the cultural, economical and political 
context.
Operational research is characterized by a “systems 
orientation, or systems engineering, in which interdisci-
plinary research teams adapt scientiﬁ c methods to large-
scale problems that must be modeled” [10]. In other 
words, operational research aims to provide a sound, 
rational basis for how to maximize the use of limited 
resources. Xiong et al propose that operational research 
can improve global HIV outcomes by supporting decision 
making both at a policy level, e.g., resource allocation, 
healthcare workforce planning and infrastructure plan-
ning, and at an operational level, e.g., demand fore-
casting, supply chain design, service benchmarking and 
service integration, many of which necessitate robust and 
reliable data collection and reporting [11]. Ultimately, 
addressing the operational obstacles lie at the heart of a 
successful response to the HIV epidemic.
In this special issue, the Journal of the International 
AIDS Society aims to highlight some of the operational 
and programmatic challenges that are faced in sub-
Saharan Africa today, where the largest population of 
people living with HIV resides and where health 
expenditure and health infrastructure often fall short of 
the demands.
Th is supplement includes six articles on a diverse range 
of topics, from vital registries and reporting to various 
steps in programme delivery. We envisage that this 
supplement will serve to familiarize readers with a range 
of system matters encountered in the context of HIV 
clinical management in sub-Saharan Africa.
Th e ﬁ rst article in this supplement by Dlodlo et al 
shows the devastating impact of the HIV epidemic on the 
crude mortality in the two main cities of Zimbabwe 
(Harare and Bulawayo) due to a substantial increase in 
AIDS-related mortality. Th e authors further demonstrate 
how turning that tide is a challenging task; despite a 56% 
ART coverage, the crude mortality in Zimbabwe has 
declined by merely 19%. Th e paper highlights the impor-
tance of data collection and the value of using traditional 
data collection tools (the city council registries) that have 
withstood the test of time and the hugely changing 
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economic circumstances that have occurred over the 30 
years of this data collection study. Moreover, the paper 
shows how useful vital registries are in identifying the 
underlying factors and causes for increased mortality and 
morbidity, as well as how such data can be used to 
measure the impact of programmes at a population level.
Th e availability of human resources in primary health-
care and associated general health outcomes is investi-
gated by Rasschaert and colleagues. Th is article provides 
examples from Malawi and Ethiopia. Th ese countries, 
though diﬀ erent in size and population, have similar 
rankings on the Human Development Index, and both 
suﬀ er from weak health infrastructures, shortages in the 
health workforce and low per capita health expenditure. 
Th e authors demonstrate how changes in human 
resources policies and addressing those shortcoming 
through task shifting and investment in functional 
health care facilities have had a beneﬁ cial impact on the 
broader health outcome in those countries as observed 
by some indicators, e.g., an increase in antenatal clinic 
attendance, a higher proportion of deliveries at health 
facilities, measles immunizations, and declines in 
maternal and under-ﬁ ve mortality.
Optimizing supply chain management has historically 
been a key area of focus of the operational research 
community. Schouten et al share their experiences in 
establishing a national ARV procurement mechanism in 
a changing environment in Malawi. Initially fairly 
straight forward with a single ﬁ rst-line ARV regimen, the 
drug forecasting and procurement system has become 
more complicated with increasing numbers of diﬀ erent 
regimens (e.g., alternative ﬁ rst line, second line and 
paediatric) and increasing volumes of drugs. Th e authors 
highlight that management of supply of various volumes 
of diﬀ erent ARV drugs requires a rethinking and a need 
for a dedicated forecasting and procurement team, a 
national buﬀ er stock, storehouse capacity and a stream-
lining of the grant disbursement mechanism; these are 
issues that are also relevant to other sub-Saharan African 
contexts.
Th e daunting challenge of preventing, treating and 
managing TB among people living with HIV is described 
by Sculier et al. Despite eﬀ ective measures to prevent, 
detect and treat TB, programmatic challenges result in 
TB remaining the leading cause of death in people living 
with HIV. In their paper, Sculier and co-authors provide 
an overview of available evidence and tools to scale up 
and integrate TB prevention and treatment with HIV 
programmes and improve the management of HIV-TB 
co-infections.
Reduction in viral load following eﬀ ective treatment 
can substantially reduce the risk of HIV transmission. 
Early and widespread use of treatment, if implemented, is 
hypothesized to have a substantial impact on the HIV 
incidence in a community. Th e gold standard for testing 
the eﬃ  cacy of this intervention can be provided by 
community randomized controlled trials. However, there 
remains a great deal of operational challenges to conduct-
ing such trials, and these are discussed by Williams et al. 
In their article, Williams et al examine the theoretical 
operational issues that need to be addressed, the 
obstacles to be overcome and the strategies that will need 
to be implemented for the community randomized trials 
to be successful in providing adequate evidence for the 
concept of treatment as prevention.
Finally, in a commentary with a futuristic perspective, 
Zachariah et al call for strengthening the operational 
research capacity and urge for accelerated research and 
proactive planning. Th e authors outline some of the 
current obstacles in reaching universal access in sub-
Saharan Africa, and propose approaches that can 
considerably change the pace and make an impact on this 
epidemic. Key challenges for the future include: sustain-
ability of funding for scale up; managing an ever-growing 
cohort on ART; getting those waiting for ART onto 
treatment; monitoring cohorts and ensuring long-term 
adherence; and investing in HIV prevention. Building 
capacity for operational research in order to provide 
answers to these challenges is urgently required.
From this special issue, we hope that readers may gain 
insight into some of the operational and programmatic 
challenges that are associated with the HIV/AIDS 
epidemic and a changing environment in sub-Saharan 
Africa, and become familiar with some applications of 
operational research and implementation science in HIV 
healthcare settings. Th e Journal of International AIDS 
Society accepts submissions in all disciplines and is parti-
cularly committed to prioritizing publications of opera-
tional research articles. We therefore strongly encourage 
submissions in this area and warmly welcome contri bu-
tions that present innovative operational models or 
techniques that can help advance the scale up and 
optimization of care delivery in high-HIV-prevalence 
settings.
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